Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 2:53 pm Sale | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIV | ARMISTICE CAPITAL LLC | 163,100 4.99% | -81,899 (-33.43%) | View |
| 2024-02-13 8:09 pm Purchase | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIV | Lind Global Fund II LP | 125,520 3.9% | 125,520 (New Position) | View |
| 2024-02-06 12:08 pm Sale | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIV | Foose Brice | 0 0% | -330,000 (Position Closed) | View |
| 2023-04-25 5:37 pm Purchase | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIV | Foose Brice | 330,000 11.5% | 330,000 (New Position) | View |
| 2023-02-14 1:13 pm Purchase | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIV | ARMISTICE CAPITAL LLC | 244,999 9.99% | 244,999 (New Position) | View |
| 2023-02-13 4:25 pm Purchase | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIV | Lind Global Macro Fund LP | 128,321 6.3% | 128,321 (New Position) | View |
| 2022-02-11 07:24 am Sale | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIV | INTRACOASTAL CAPITAL LLC | 864,933 2.5% | -690,782 (-44.40%) | View |
| 2022-02-09 5:02 pm Purchase | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIV | Lind Global Macro Fund LP | 3,138,000 8.4% | 868,975 (+38.30%) | View |
| 2021-02-16 10:02 am Purchase | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIV | CVI Investments Inc. | 1,018,701 4.8% | 561,558 (+122.84%) | View |
| 2021-02-09 4:46 pm Sale | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIV | L1 Capital Global Opportunities Master Fund Ltd. | 1,061,250 4.8% | -1,061,250 (-50.00%) | View |
| 2021-02-03 4:33 pm Sale | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIV | BIGGER CAPITAL FUND L P | 387,500 11% | -987,500 (-71.82%) | View |
| 2021-01-29 06:23 am Purchase | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIV | INTRACOASTAL CAPITAL LLC | 1,555,715 6.8% | 1,250,000 (+408.88%) | View |
| 2021-01-20 4:31 pm Purchase | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIV | Lind Global Macro Fund LP | 2,269,025 9.9% | 653,775 (+40.48%) | View |
| 2021-01-05 3:43 pm Purchase | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIV | SABBY MANAGEMENT LLC | 1,056,475 11% | 580,284 (+121.86%) | View |
| 2020-11-02 5:29 pm Purchase | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIV | BIGGER CAPITAL FUND L P | 1,375,000 5.8% | 1,375,000 (New Position) | View |
| 2020-11-02 4:10 pm Purchase | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIV | L1 Capital Global Opportunities Master Fund Ltd. | 2,122,500 8.6% | 2,122,500 (New Position) | View |
| 2020-10-23 4:38 pm Purchase | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIV | Lind Global Macro Fund LP | 1,615,250 9.9% | 1,615,250 (New Position) | View |
| 2020-04-24 5:04 pm Purchase | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIV | ARMISTICE CAPITAL LLC | 254,597 4.99% | 143,221 (+128.59%) | View |
| 2020-04-24 4:14 pm Purchase | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIV | INTRACOASTAL CAPITAL LLC | 305,715 5.9% | 305,715 (New Position) | View |
| 2020-04-24 11:18 am Purchase | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIV | CVI Investments Inc. | 457,143 9.4% | 457,143 (New Position) | View |